| # | Drug | Count |
|---|---|---|
| 0 | CABOTEGRAVIR AND RILPIVIRINE | 514 |
| 1 | RILPIVIRINE | 465 |
| 2 | CABOTEGRAVIR | 434 |
| 3 | RIBAVIRIN | 381 |
| 4 | TENOFOVIR DISOPROXIL FUMARATE | 224 |
| 5 | LAMIVUDINE | 210 |
| 6 | LAMIVUDINE ORAL | 210 |
| 7 | RITONAVIR | 197 |
| 8 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 178 |
| 9 | RITONAVIR 100 MG | 129 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIUM SILICATE | 1 | 0.5000 |
| 1 | IBALIZUMAB | 45 | 0.0833 |
| 2 | CABOTEGRAVIR AND RILPIVIRINE | 514 | 0.0786 |
| 3 | CABOTEGRAVIR SODIUM | 110 | 0.0685 |
| 4 | RILPIVIRINE | 465 | 0.0651 |
| 5 | ADEFOVIR DIPIVOXIL | 77 | 0.0606 |
| 6 | CABOTEGRAVIR | 434 | 0.0529 |
| 7 | MARIBAVIR | 128 | 0.0518 |
| 8 | FOSTEMSAVIR TROMETHAMINE | 12 | 0.0494 |
| 9 | BULEVIRTIDE | 4 | 0.0417 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD4-directed Blocking Antibody [EPC] | 45 | 0.0833 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 128 | 0.0518 |
| 2 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 3 | CCR5 Co-receptor Antagonist [EPC] | 30 | 0.0131 |
| 4 | Interferon gamma Blocker [EPC] | 3 | 0.0127 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 470 | 0.0096 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 856 | 0.0078 |
| 7 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 25 | 0.0077 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 463 | 0.0077 |
| 9 | Protease Inhibitor [EPC] | 338 | 0.0076 |